What did Martis Capital pay for Three Oaks Hospice?

Martis Capital acquired Three Oaks Hospice for $155.0M in 2024 (13.5x EBITDA). Target EBITDA was approximately $11.5M.

What does Three Oaks Hospice do?

Three Oaks Hospice is a hospice business.

What multiple did Martis Capital pay for Three Oaks Hospice?

13.5x EBITDA, based on disclosed deal value of $155.0M and disclosed financials.

M&A TRANSACTION · 2024

Three Oaks Hospice acquired by Martis Capital

$155.0M· 13.5x EBITDA

Target

Three Oaks Hospice

Acquirer

Martis Capital

Disclosed financials at time of acquisition

Revenue

—

EBITDA

$11.5M

Deal Value

$155.0M

EV/EBITDA

13.5x

Context

This $155.0M acquisition of Three Oaks Hospice by Martis Capital sits in the hospice sub-vertical. The 13.5x EBITDA multiple paid in 2024 can be compared against the population median for hospice transactions of similar size on our Hospice valuation hub.

Source

Data sourced from Press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own hospice

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Three Oaks Hospice acquisition.

Citation: ExitValue.ai. (2024). Three Oaks Hospice acquired by Martis Capital. https://exitvalue.ai/deals/three-oaks-hospice-acquired-by-martis-capital-hc-2024-0021